Thomas N. Kledal

1.5k citations
15 papers · 1.2k indexed · h-index 12
Topics
Cytomegalovirus and herpesvirus research (7 papers)Viral-associated cancers and disorders (6 papers)Herpesvirus Infections and Treatments (5 papers)

In The Last Decade

Thomas N. Kledal

15 papers receiving 1.1k citations

Peers

Thomas N. Kledal
Comparison fields: 5 of 81
  • Oncology 600
  • Immunology 445
  • Epidemiology 441
  • Molecular Biology 265
  • Physiology 112
Replace Lianxian Cui with:
Lianxian Cui China
Dan Zhou China
Antonio Alcina Spain
Mauro Biffi Italy
Andy Tsun China
Munir Akkaya United States
Sunil S. Metkar United States
Matheus Carvalho Bürger Brazil
Jens‐Uwe Vogel Germany
Rafael J. Argüello France
Thomas N. Kledal relative to Lianxian Cui China Lianxian Cui's profile →
Citations per field
00.5×1.5×2.4×
Lianxian Cui · 1×
Citations per year

Countries citing papers authored by Thomas N. Kledal

Since Specialization
Citations

This map shows the geographic impact of Thomas N. Kledal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas N. Kledal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas N. Kledal more than expected).

Fields of papers citing papers by Thomas N. Kledal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas N. Kledal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas N. Kledal. The network helps show where Thomas N. Kledal may publish in the future.

Co-authorship network of co-authors of Thomas N. Kledal

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas N. Kledal. A scholar is included among the top collaborators of Thomas N. Kledal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas N. Kledal. Thomas N. Kledal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 10
2 22
3 50
4 9
5 3
6 40
7 91
8 56
9 52
10 125
11 104
12 13
13 51
14 161
15 376

About Thomas N. Kledal

Thomas N. Kledal is a scholar working on Biological Psychiatry, Parasitology and Oncology, having authored 15 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (7 papers), Viral-associated cancers and disorders (6 papers) and Herpesvirus Infections and Treatments (5 papers). The work is most often cited by research in Oncology (600 citations), Immunology (445 citations) and Virology (95 citations). Thomas N. Kledal has collaborated with scholars based in Denmark, Canada and United Kingdom. Frequent co-authors include Mette M. Rosenkilde, Thue W. Schwartz, Hans Bräuner‐Osborne, Hans Rudolf Lüttichau, Ian Clark‐Lewis, Edward S. Mocarski, Jesper Eugen‐Olsen, Paul R. Clapham, Christopher Power and Jan Gerstoft. Their work appears in journals such as Science, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026